Renal involvement in Systemic Lupus Erythematous is common and its management remains a daily challenge
for clinical providers. Percutaneous kidney biopsy remains the gold standard for diagnosis of lupus nephritis.
More recently, we have seen the role of the biopsy being challenged, considering the widespread use of corticosteroids and mycophenolate mofetil for all forms of lupus nephritis. We present a review of published evidence
regarding first and repeat kidney biopsies for patients with lupus nephritis. Based on the available literature, we
recommend a kidney biopsy to guide treatment and determine prognosis and we also suggest an algorithm for kidney rebiopsy in lupus nephritis.info:eu-repo/semantics/publishedVersio
